• News
  • SAN DIEGO
  • BioTech

Medicines Company buys SD infection drug developer

Medicines Co. has acquired a San Diego-based privately held drugmaker that has developed several potential treatments for serious infections in a deal that could be worth more than $400 million.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!